Correlation Between Icosavax and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Icosavax and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Effector Therapeutics, you can compare the effects of market volatilities on Icosavax and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Effector Therapeutics.
Diversification Opportunities for Icosavax and Effector Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Icosavax and Effector is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Icosavax and Effector Therapeutics
Given the investment horizon of 90 days Icosavax is expected to generate 0.65 times more return on investment than Effector Therapeutics. However, Icosavax is 1.54 times less risky than Effector Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 1,072 in Icosavax on November 2, 2024 and sell it today you would lose (170.00) from holding Icosavax or give up 15.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 32.0% |
| Values | Daily Returns |
Icosavax vs. Effector Therapeutics
Performance |
| Timeline |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Icosavax and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icosavax and Effector Therapeutics
The main advantage of trading using opposite Icosavax and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |